The three factors function as an interconnected regulatory network rather than as isolated switches. Their coordinated expression supports activation of genes associated with pluripotency while helping repress gene programs linked to differentiation. This arrangement matters because maintaining cell identity depends on simultaneous control of genes that preserve the undifferentiated state and genes that could redirect cell fate.
Binding to regulatory DNA gives Oct4, Sox2, and Nanog a direct way to influence which genes are active or repressed. Through these regulatory interactions, the factors promote pluripotency-associated gene expression while suppressing differentiation programs. Their DNA-binding activity therefore connects molecular control at gene regulatory regions with the broader maintenance of embryonic stem cell identity.
Coordinated expression keeps the activities of the three transcription factors aligned with one another. When this regulatory state is maintained, pluripotency-associated genes remain supported and differentiation-related programs remain restrained. The balance is important because cell fate depends not only on activating genes linked to an undifferentiated state, but also on preventing competing developmental programs from becoming dominant.
Researchers can examine the network by relating the factors' expression and regulatory DNA binding to changes in pluripotency-associated and differentiation-associated gene programs. This approach connects molecular regulatory activity with the cell's identity state. Studying those relationships helps clarify how cell fate is established and maintained during early development and in experimental stem cell systems.
The network provides a biological framework for studying how cell identity can be altered during cellular reprogramming. It also supports stem cell-based disease modeling, where researchers can investigate the consequences of disrupted identity or differentiation control in relevant cellular systems. These applications extend the study of Oct4, Sox2, and Nanog beyond early development into experimental models of disease.
Because the network regulates pluripotency and differentiation programs, altered transcriptional control can be examined in relation to developmental disorders and cancer. Its study also informs regenerative medicine by clarifying the mechanisms that maintain or change cellular identity. Together, these contexts make the factors useful for connecting basic developmental biology with disease research and potential cell-based applications.